NPHC DD: O/S 1.9 Billion https://www.otcmark
Post# of 102
(Total Views: 854)
Posted On: 01/16/2018 1:02:03 PM
NPHC DD:
O/S 1.9 Billion
https://www.otcmarkets.com/stock/NPHC/profile
Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration
https://finance.yahoo.com/news/nutra-pharmas-...00069.html
Nyloxin Drug: All-natural, anti-inflammatory, analgesic pain relief that is non-toxic, non-narcotic, non-addictive, non-steroidal and does not contain aspirin or acetaminophen
https://nyloxin.com
Recent Shareholders Letter: A MUST READ
www.nutrapharma.com/Dec2017_shareholder_letter.pdf
ReceptoPharm R&D Pipeline
www.receptopharm.com/drug_development/pipeline.php
O/S 1.9 Billion
https://www.otcmarkets.com/stock/NPHC/profile
Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration
https://finance.yahoo.com/news/nutra-pharmas-...00069.html
Nyloxin Drug: All-natural, anti-inflammatory, analgesic pain relief that is non-toxic, non-narcotic, non-addictive, non-steroidal and does not contain aspirin or acetaminophen
https://nyloxin.com
Recent Shareholders Letter: A MUST READ
www.nutrapharma.com/Dec2017_shareholder_letter.pdf
ReceptoPharm R&D Pipeline
www.receptopharm.com/drug_development/pipeline.php
(0)
(0)Nutra Pharma Corp. (NPHC) Stock Research Links
Scroll down for more posts ▼